OBJECTIVE: This is a retrospective study aimed at clarifying the details of recurrence patterns and sites in @entity1 with @entity5 treated with definitive @entity1161 ( @entity1161 ). METHODS: Data were analyzed from consecutive @entity1 , admitted to our institution between 2001 and 2013, who had received definitive @entity1161 , with or without chemotherapy, for International Federation of Gynecology and Obstetrics stages IB. @entity5 . RESULTS: One hundred and thirty-seven @entity1 formed the @entity1 cohort. The median follow-up period for surviving @entity1 was 57.0 months. A complete response was achieved in 121 (88%) @entity1 . Of these, 36 (30%) developed a @entity5 recurrence during follow-up. The first sites of recurrence were located in intra- @entity1161 fields in nine, outside @entity1161 fields in 20, and both in seven @entity1 . In the intra- @entity1161 field group, all @entity1 showed a local recurrence, while no one experienced an isolated @entity1600 ( @entity1600 ) recurrence. In the outside @entity1161 field group, the most frequent site of recurrence was lung (60%), and three-quarters of @entity1 were free from intra- @entity1161 field recurrence until the last follow-up. Of the entire cohort, including 48 @entity1600 -positive @entity1 , only seven (5.1%) @entity1 developed @entity1600 persistence or recurrence, all in the common iliac, internal iliac, and/or obturator nodes, and all with another synchronous relapse. CONCLUSION: @entity66 was a major type of intra- @entity1161 field recurrence, while @entity1600 control was favorable even in initially @entity1600 -positive @entity1 . The predominance of outside @entity1161 field recurrence alone highlights issues concerning distant control, including the intensity enhancement of systematic therapy.

Details of recurrence sites after definitive @entity1161 for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity66 :: ('MESH:D004194', 'Disease') :: ['Local disease'] @entity5 :: ('MESH:D009369', 'Disease') :: ['IVA cervical cancer', 'cancer', 'cervical cancer'] @entity1161 :: ('MESH:D011832', 'Disease') :: ['radiation therapy', 'RT'] @entity1600 :: ('MESH:D014388', 'Disease') :: ['PLN', 'pelvic lymph node']
@entity5 :: (MESH:D009369,Disease) :: ['cervical cancer']
